Stay updated on Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added a new bibliographic reference (NPJ Breast Cancer, 2025) about biomarkers and outcomes in metastatic TNBC treated with pembrolizumab/chemotherapy; no deletions observed.
    Difference
    2%
    Check dated 2025-10-12T14:32:45.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    2%
    Check dated 2025-10-05T10:04:50.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0. This signals a software update; no other content changes are indicated.
    Difference
    0.1%
    Check dated 2025-09-28T03:12:14.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    - Updated the page revision from v3.0.1 to v3.0.2. - Removed the Back to Top link; no other substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-13T17:36:31.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-06T15:13:41.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated to include new drug information and references related to pembrolizumab and other treatments for triple-negative breast cancer, while some previous content has been removed, including specific location details and certain drug classifications.
    Difference
    7%
    Check dated 2025-08-30T11:51:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Chemo in Metastatic TNBC Clinical Trial page.